BioCentury
ARTICLE | Clinical News

Virulizin: A Phase I/II trial

May 23, 1994 7:00 AM UTC

Imutec Corp. (IMUTF), Ontario Product: Virulizin, a natural stimulator of killer cells Indication: Advanced Kaposi's sarcoma Status: A Phase I/II trial is slated to start by mid-June. Safety, toxicit...